Godshall Douglas Evan's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed May 13, 2022
- Accession no.
- 0001209191-22-029012
- Filed
- May 13, 2022
- Trade date
- May 13, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $750.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Godshall Douglas EvanCIK 0001404227 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $3.42 | +$17,100 | 147,926 | Direct | |
| May 13, 2022 | Common Stock | SSaleDisposed | −5,000 | $150.00F2 | −$750,000 | 142,926 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 464,799 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
All reported securities were sold at a price of $150.00.
Referenced by the price of 1 transaction in Table I.